Annual EBIT
-$50.36 M
-$8.71 M-20.91%
31 December 2023
Summary:
Compass Therapeutics annual earnings before interest & taxes is currently -$50.36 million, with the most recent change of -$8.71 million (-20.91%) on 31 December 2023. During the last 3 years, it has fallen by -$21.80 million (-76.34%). CMPX annual EBIT is now -76.34% below its all-time high of -$26.16 million.CMPX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$12.24 M
+$2.81 M+18.65%
01 September 2024
Summary:
Compass Therapeutics quarterly earnings before interest & taxes is currently -$12.24 million, with the most recent change of +$2.81 million (+18.65%) on 01 September 2024. Over the past year, it has dropped by -$313.00 thousand (-2.62%). CMPX quarterly EBIT is now -130.97% below its all-time high of -$5.30 million, reached on 01 June 2020.CMPX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$55.45 M
-$313.00 K-0.57%
01 September 2024
Summary:
Compass Therapeutics TTM earnings before interest & taxes is currently -$55.45 million, with the most recent change of -$313.00 thousand (-0.57%) on 01 September 2024. Over the past year, it has dropped by -$7.58 million (-15.85%). CMPX TTM EBIT is now -554.71% below its all-time high of -$8.47 million, reached on 01 June 2019.CMPX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CMPX EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -20.9% | -2.6% | -15.8% |
| 3 y3 years | -76.3% | -107.5% | +28.1% |
| 5 y5 years | -34.6% | -49.0% | -232.4% |
CMPX EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -76.3% | +38.4% | -107.5% | +20.5% | -58.3% | +32.2% |
| 5 y | 5 years | -76.3% | +38.4% | -131.0% | +78.0% | -232.4% | +32.2% |
| alltime | all time | -76.3% | +38.4% | -131.0% | +78.0% | -554.7% | +32.2% |
Compass Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$12.24 M(-18.7%) | -$55.45 M(+0.6%) |
| June 2024 | - | -$15.04 M(+17.8%) | -$55.13 M(+3.2%) |
| Mar 2024 | - | -$12.77 M(-17.0%) | -$53.43 M(+6.1%) |
| Dec 2023 | -$50.36 M(+20.9%) | -$15.39 M(+29.1%) | -$50.37 M(+5.2%) |
| Sept 2023 | - | -$11.93 M(-10.6%) | -$47.86 M(-1.4%) |
| June 2023 | - | -$13.34 M(+37.3%) | -$48.53 M(+9.8%) |
| Mar 2023 | - | -$9.71 M(-24.7%) | -$44.18 M(+6.1%) |
| Dec 2022 | -$41.66 M(-49.1%) | -$12.89 M(+2.3%) | -$41.66 M(-0.2%) |
| Sept 2022 | - | -$12.60 M(+40.2%) | -$41.72 M(+19.1%) |
| June 2022 | - | -$8.99 M(+25.1%) | -$35.02 M(-57.1%) |
| Mar 2022 | - | -$7.18 M(-44.6%) | -$81.71 M(-0.1%) |
| Dec 2021 | -$81.81 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | - | -$12.96 M(+119.7%) | -$81.81 M(+6.2%) |
| Sept 2021 | - | -$5.90 M(-89.4%) | -$77.07 M(-3.8%) |
| June 2021 | - | -$55.68 M(+664.8%) | -$80.11 M(+169.5%) |
| Mar 2021 | - | -$7.28 M(-11.4%) | -$29.73 M(+4.1%) |
| Dec 2020 | -$28.56 M(-14.6%) | -$8.21 M(-8.1%) | -$28.56 M(+7.1%) |
| Sept 2020 | - | -$8.94 M(+68.7%) | -$26.66 M(+2.8%) |
| June 2020 | - | -$5.30 M(-13.3%) | -$25.94 M(-10.9%) |
| Mar 2020 | - | -$6.11 M(-3.3%) | -$29.11 M(+26.6%) |
| Dec 2019 | -$33.42 M(-10.7%) | -$6.32 M(-23.1%) | -$23.00 M(+37.9%) |
| Sept 2019 | - | -$8.21 M(-3.0%) | -$16.68 M(+97.0%) |
| June 2019 | - | -$8.47 M | -$8.47 M |
| Dec 2018 | -$37.42 M | - | - |
FAQ
- What is Compass Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Compass Therapeutics?
- What is Compass Therapeutics annual EBIT year-on-year change?
- What is Compass Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Compass Therapeutics?
- What is Compass Therapeutics quarterly EBIT year-on-year change?
- What is Compass Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Compass Therapeutics?
- What is Compass Therapeutics TTM EBIT year-on-year change?
What is Compass Therapeutics annual earnings before interest & taxes?
The current annual EBIT of CMPX is -$50.36 M
What is the all time high annual EBIT for Compass Therapeutics?
Compass Therapeutics all-time high annual earnings before interest & taxes is -$26.16 M
What is Compass Therapeutics annual EBIT year-on-year change?
Over the past year, CMPX annual earnings before interest & taxes has changed by -$8.71 M (-20.91%)
What is Compass Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of CMPX is -$12.24 M
What is the all time high quarterly EBIT for Compass Therapeutics?
Compass Therapeutics all-time high quarterly earnings before interest & taxes is -$5.30 M
What is Compass Therapeutics quarterly EBIT year-on-year change?
Over the past year, CMPX quarterly earnings before interest & taxes has changed by -$313.00 K (-2.62%)
What is Compass Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of CMPX is -$55.45 M
What is the all time high TTM EBIT for Compass Therapeutics?
Compass Therapeutics all-time high TTM earnings before interest & taxes is -$8.47 M
What is Compass Therapeutics TTM EBIT year-on-year change?
Over the past year, CMPX TTM earnings before interest & taxes has changed by -$7.58 M (-15.85%)